Co-Authors
This is a "connection" page, showing publications co-authored by Dany Anglicheau and Nathalie Chavarot.
Connection Strength
2.343
-
Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection. Kidney Int. 2021 02; 99(2):486-488.
Score: 0.927
-
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transplant. 2021 12; 21(12):4043-4051.
Score: 0.242
-
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept. Transplantation. 2021 09 01; 105(9):e94-e95.
Score: 0.241
-
[COVID-19 vaccination in dialysis and kidney transplant patients]. Nephrol Ther. 2021 Aug; 17(4):208-213.
Score: 0.238
-
Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient. Kidney Int. 2021 03; 99(3):767-768.
Score: 0.231
-
COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant. 2021 03; 21(3):1285-1294.
Score: 0.231
-
Clinical Utility of Biochemical Markers for the Prediction of COVID-19-Related Mortality in Kidney Transplant Recipients. Kidney Int Rep. 2021 Oct; 6(10):2689-2693.
Score: 0.060
-
Occurrence of severe COVID-19 in vaccinated transplant patients. Kidney Int. 2021 08; 100(2):477-479.
Score: 0.059
-
Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant. 2021 03; 21(3):1295-1303.
Score: 0.058
-
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants. Kidney Int. 2020 12; 98(6):1549-1558.
Score: 0.056